Young infants are generally more susceptible to viral infections and experience more severe disease than adults. CD8+ T cells are important for viral clearance and although often ineffective in neonates can be protective if adequately stimulated. Using a murine CB6F1/J hybrid model of respiratory syncytial virus (RSV) infection, we previously demonstrated that the CD8+ T cell immunodominance hierarchy to two RSV-derived epitopes, KdM282–90, and DbM187–195, was determined by the age at infection. To determine if age-dependent RSV specific CD8+ T cell responses could be modified through enhanced innate signaling, we used toll-like receptor (TLR) agonist 4 or 9 treatment at the time of infection, which remarkably changed the neonatal codominant response to an adult-like KdM282–90 CD8+ T cell immunodominant response. This shift was associated with an increase in the number of conventional dendritic cells (cDCs), CD11b+ and CD103+ DCs, in the lung-draining lymph node, and increased expression of the co-stimulatory molecule CD86. The magnitude of the KdM282–90 CD8+ T cell response in TLR-treated neonates could be blocked with antibodies against CD80 and CD86. These studies demonstrate the age-dependent function of cDCs, their role in determining immunodominance hierarchy, and epitope-specific CD8+ T cell requirements for co-stimulation that all influence the immune response magnitude. The unique impact of TLR agonists on neonatal T cell responses is important to consider for RSV vaccines designed for young infants.